Güner, Y. E. Et Al. 2022. Does MDR1 promoter methylation affect temozolomide resistance? A clinical study in patients with glioblastoma MDR1 promoter metilasyonu temozolomid direncini etkiler mi? Glioblastomlu hastalarda klinik çalışma. Pamukkale Medical Journal , vol.15, no.3 , 547-554.

Güner, Y. E., BAYATLI, E., Kızıldoğan, A. K., GÖKMEN, D., Yüksek, V., Taşpınar, F., ... TETİK, B.(2022). Does MDR1 promoter methylation affect temozolomide resistance? A clinical study in patients with glioblastoma MDR1 promoter metilasyonu temozolomid direncini etkiler mi? Glioblastomlu hastalarda klinik çalışma. Pamukkale Medical Journal , vol.15, no.3, 547-554.

Güner, Yahya Et Al. "Does MDR1 promoter methylation affect temozolomide resistance? A clinical study in patients with glioblastoma MDR1 promoter metilasyonu temozolomid direncini etkiler mi? Glioblastomlu hastalarda klinik çalışma," Pamukkale Medical Journal , vol.15, no.3, 547-554, 2022

Güner, Yahya E. Et Al. "Does MDR1 promoter methylation affect temozolomide resistance? A clinical study in patients with glioblastoma MDR1 promoter metilasyonu temozolomid direncini etkiler mi? Glioblastomlu hastalarda klinik çalışma." Pamukkale Medical Journal , vol.15, no.3, pp.547-554, 2022

Güner, Y. E. Et Al. (2022) . "Does MDR1 promoter methylation affect temozolomide resistance? A clinical study in patients with glioblastoma MDR1 promoter metilasyonu temozolomid direncini etkiler mi? Glioblastomlu hastalarda klinik çalışma." Pamukkale Medical Journal , vol.15, no.3, pp.547-554.

@article{article, author={Yahya Efe Güner Et Al. }, title={Does MDR1 promoter methylation affect temozolomide resistance? A clinical study in patients with glioblastoma MDR1 promoter metilasyonu temozolomid direncini etkiler mi? Glioblastomlu hastalarda klinik çalışma}, journal={Pamukkale Medical Journal}, year=2022, pages={547-554} }